Hatfield, PA, United States of America

C Blair Zartman

USPTO Granted Patents = 27 


 

Average Co-Inventor Count = 5.9

ph-index = 11

Forward Citations = 230(Granted Patents)


Location History:

  • Hartfield, PA (US) (2007)
  • Hatfield, PA (US) (2002 - 2019)

Company Filing History:


Years Active: 2002-2019

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):

Title: The Innovative Contributions of C Blair Zartman

Introduction

C Blair Zartman, an accomplished inventor based in Hatfield, PA, USA, has made significant contributions to the field of pharmacology and medicinal chemistry. With a remarkable portfolio of 27 patents, Zartman focuses on developing innovative solutions to address significant health issues, particularly those pertaining to migraines and related disorders.

Latest Patents

Among Zartman's latest innovations are the piperidinone carboxamide azaindane derivatives, which serve as antagonists of CGRP (Calcitonin Gene-Related Peptide) receptors. These compounds have broad implications in the treatment and prevention of diseases where CGRP is involved, notably migraines. The pharmaceutical compositions derived from these compounds are poised to make a significant impact on patient care by providing effective treatment options for those suffering from debilitating conditions related to CGRP.

Career Highlights

Zartman has had a distinguished career working with leading pharmaceutical companies, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. His tenure at these institutions has allowed him to collaborate on cutting-edge research and innovation, solidifying his reputation as a leading inventor in his field.

Collaborations

Throughout his career, C Blair Zartman has had the opportunity to work alongside other esteemed professionals, including Ian M Bell and Steven N Gallicchio. These collaborations underscore Zartman's commitment to fostering innovation through teamwork and interdisciplinary research, paving the way for advancements that can enhance therapeutic outcomes.

Conclusion

C Blair Zartman's innovative spirit and dedication to research have not only led to multiple patents but also contributed immensely to improving treatments in the pharmaceutical industry. His work stands as a testament to the importance of innovation in addressing complex health challenges, particularly in the realm of migraine treatment. As he continues to explore new frontiers in pharmacology, Zartman's contributions will undoubtedly leave a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…